Patent ID: 11866442
Assignee: NURIX THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 17:
18. The compound or pharmaceutically acceptable salt of claim 1, wherein the compound of Formula (A) is a compound of Formula (F), or a pharmaceutically acceptable salt thereof, wherein
W is N;
L is —X1—X2—X3—;
X1 is —C(O)—, —C(O)—N(R)—, —N(R)—C(O)—, —(O—CH2—CH2)m, —O(C6H4, —(O—CH2—CH2—CH2)m,
—C1-5 alkyl-, 7-12 membered spiro bicyclic heterocycloalkyl having 1-3 heteroatoms independently selected from N, O, or S, or 4-6 membered monocyclic heterocycloalkyl having 1-2 heteroatoms independently selected from N, O, or S, wherein each of the monocyclic and bicyclic heterocycloalkyl of X1 is optionally substituted with —CH3;

X2 is a bond, —C1-5 alkyl-, —(O—CH2—CH2)n—, —(CH2—CH2—O)n—, —N(R)—C(O)—, —N(R)—, —C(O)—, —C(O)—N(R)—, —C1-5 alkyl-, 4-6 membered monocyclic cycloalkyl, or 4-6 membered monocyclic heterocycloalkyl having 1-2 heteroatoms independently selected from N, O, or S;
X3 is a bond, —C1-4 alkyl-,, , 4-6 membered cycloalkyl, —N(R)—, —(O—CH2—CH2)p—, —(CH2—CH2—O)p—, 4-6 membered heterocycloalkyl having 1-2 heteroatoms independently selected from N, O, or S wherein the heterocycloalkyl is optionally substituted with —CH3;
each R is independently —H or —C1-3 alkyl;
each of m, n, and p is independently an integer from 1 to 3; and
Y is,